Top Court Hears Case of Jilted Wife Charged Under Chemical-Arms Law

Global Security Newswire Staff
Add to Briefcase
See more stories about...
Global Security Newswire Staff
Nov. 5, 2013, 11:02 a.m.

The U.S. Su­preme Court on Tues­day ap­peared sym­path­et­ic to a mi­cro­bi­o­lo­gist’s ar­gu­ment that she was un­fairly pro­sec­uted un­der a fed­er­al law that im­ple­ments the Chem­ic­al Weapons Con­ven­tion after she tried to pois­on a ro­mantic rival, ac­cord­ing to re­ports.

The na­tion’s top justices weighed the ap­peal of 42-year old Car­ol Ann Bond, who in 2008 pled guilty to try­ing to pois­on her hus­band’s preg­nant lov­er, Myrlina Haynes, with a chem­ic­al com­pound. Bond was charged in fed­er­al court with vi­ol­at­ing the 1998 Chem­ic­al Weapons Con­ven­tion Im­ple­ment­a­tion Act, the law the im­ple­men­ted the 1997 Chem­ic­al Weapons Con­ven­tion in the United States. She was sen­tenced to six years in pris­on and fought that con­vic­tion, ar­guing fed­er­al pro­sec­utors in­fringed upon state au­thor­ity by fil­ing charges against her un­der a law cre­ated to de­ter the use of chem­ic­al weapons by rogue na­tions and ter­ror­ists.

Most of the justices ap­peared “down­right angry” with the fed­er­al gov­ern­ment’s use of an in­ter­na­tion­al treaty to pro­sec­ute a wo­man in a do­mest­ic spat, USA Today re­por­ted. They ques­tioned if the Chem­ic­al Weapons Con­ven­tion and the law Con­gress passed im­ple­ment­ing it were in­ten­ded to reach to such do­mest­ic crimes or re­main only ap­plic­able to war­time mat­ters. At its core, the case is about wheth­er Con­gress can use its power to im­ple­ment treat­ies on loc­al mat­ters not nor­mally ap­plic­able to fed­er­al law, ac­cord­ing to Bloomberg.

It “seems un­ima­gin­able that you would bring this pro­sec­u­tion,” Justice An­thony Kennedy re­portedly told U.S. So­li­cit­or Gen­er­al Don­ald Ver­rilli, ac­cord­ing to the As­so­ci­ated Press.

Bond’s at­tor­ney, former U.S. so­li­cit­or gen­er­al Paul Clem­ent, re­ferred to his cli­ent’s crime con­sisted of “garden-vari­ety as­saults with chem­ic­als.”

Ver­rilli, though, ar­gued on be­half of Pres­id­ent Obama’s ad­min­is­tra­tion that if its treaty power were altered, U.S. ini­ti­at­ives re­lated to chem­ic­al weapons and nuc­le­ar non­pro­lif­er­a­tion could be hampered.

“There needs to be a com­pre­hens­ive ban,” Ver­rilli re­portedly ar­gued be­fore the high court. “You can’t be draw­ing these types of lines.”

Justice Elena Kagan, mean­while, main­tained that the Chem­ic­al Weapons Con­ven­tion and con­gres­sion­al im­ple­ment­a­tion of the treaty were sound and there­fore para­mount, USA Today re­por­ted. If they were not, judges would “take the place of treaty-makers,” she re­portedly said.

What We're Following See More »
INDEX UP MORE THAN 20% SINCE ELECTION
Dow Jones Hits 23,000 Threshold
1 hours ago
THE DETAILS
THE QUESTION
How Much Did George Soros Transfer to His Philanthropy?
1 hours ago
THE ANSWER

$18 billion. Open Society Foundations "has vaulted to the top ranks of philanthropic organizations, appearing to become the second largest in the U.S. by assets after the Bill and Melinda Gates Foundation, based on 2014 figures from the National Philanthropic Trust."

Source:
THE QUESTION
How Much Has Trump’s Fortune Fallen in One Year?
2 hours ago
THE ANSWER

About $600 million, according to a Forbes analysis. His free cash is down by $100 million.

Source:
WROTE LAW THAT WEAKENED OPIOID OVERSIGHT
Trump: Marino Withdrawing Nomination for Drug Czar
3 hours ago
THE LATEST
RAQQA TAKEN BY U.S.-BACKED MILITIAS
Last ISIS Syrian Stronghold Falls
3 hours ago
THE DETAILS

"US-backed militias have taken the Syrian city of Raqqa from the Islamic State, the Syrian Observatory for Human Rights said on Tuesday. US-backed Syrian Democratic Forces raised a militia flag inside Raqqa stadium on Tuesday, one of the last remaining areas that were held by the Islamic State in its former capital, a Reuters witness said."

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login